Thalassaemia: open trials in Germany

• NCT06609226

  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Charite Universitaetsmedizin Berlin KöR, Berlin · Medical Center- University of Freiburg, Freiburg im Breisgau

  Registry updated 2026-09-18

• NCT04208529

  A Long-term Follow-up Study in Participants Who Received CTX001

  Trial Treatment · Phase 3 · Vertex Pharmaceuticals Incorporated

  Universitaetsklinikum Duesseldorf AöR, Duesseldorf · Universitaetsklinikum Regensburg AöR, Regensburg · Universitaetsklinikum Tuebingen AöR, Tuebingen

  Registry updated 2026-08-11

• NCT04143724

  Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

  Trial Treatment · Phase 2 · Celgene

  Universitaetsklinikum Essen (AoR), Essen · Universitaetsklinikum Ulm AoR, Ulm

  Registry updated 2026-07-10

• NCT04064060

  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  Trial Treatment · Phase 3 · Celgene

  Berlin · Dresden · Düsseldorf · Düsseldorf · Halle · Hamburg · Hanover · Leipzig · Mainz · München

  Registry updated 2026-07-01

• NCT05477563

  Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

  Trial Treatment · Phase 3 · Vertex Pharmaceuticals Incorporated

  Universitaetsklinikum Duesseldorf AöR, Duesseldorf

  Registry updated 2026-03-23

All Thalassaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error